Recent genetic and epidemiological studies showed that reduced Gpx4 levels or reduced catalytic activity led to obesity, cardiovascular disease, and inflammation [38–40]. The gene discussed is GPX4; the disease is obesity due to melanocortin 4 receptor deficiency.